Checkpoint inhibition therapy as possible frontline therapy for Hodgkin lymphoma

Arushi Khurana, Philippe Armand, Stephen M. Ansell

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Checkpoint inhibition therapy as possible frontline therapy for Hodgkin lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences